Related Experiment Videos
[Cultures of islet cells obtained from the fetal bovine pancreas]
Abstract:
The pancreas from bovine fetuses of 27-35 cm crown-rump length were used as a source of islet cell cultures. Pancreatic tissue was treated by collagenase, filtered through the metal sieve and incubated in MEM for 24 h. Using this method, cultures similar to so-called pseudo-islets were obtained. Aldehyde-fuchsin staining and electron microscopy revealed a significant number of beta-cells within the pseudo-islets, the insulin-producing activity of which was confirmed by RIA.
Insights
Researchers developed a method to culture bovine fetal pancreatic tissue, creating pseudo-islets. These pseudo-islets contain insulin-producing beta-cells, confirmed by RIA testing.
Area of Science:
- Endocrinology and Metabolism
- Cell Biology
- Biotechnology
Background:
- Islet cell transplantation is a potential therapy for diabetes.
- Generating sufficient functional islet cells remains a challenge.
- Bovine fetuses offer a potential source for islet cell research.
Purpose of the Study:
- To establish a method for culturing bovine fetal pancreatic tissue.
- To characterize the resulting cell cultures for beta-cell content and function.
Main Methods:
- Pancreatic tissue was harvested from bovine fetuses (27-35 cm crown-rump length).
- Tissue was digested with collagenase and filtered.
- Cells were cultured in Minimum Essential Medium (MEM) for 24 hours.
- Pseudo-islets were analyzed using aldehyde-fuchsin staining and electron microscopy.
- Insulin production was confirmed by radioimmunoassay (RIA).
Main Results:
- A method yielding pseudo-islet-like cell cultures was successfully developed.
- Aldehyde-fuchsin staining and electron microscopy confirmed the presence of beta-cells.
- Radioimmunoassay (RIA) verified the insulin-producing capacity of these beta-cells.
Conclusions:
- Bovine fetal pancreas can be processed to generate pseudo-islets.
- These pseudo-islets contain functional, insulin-producing beta-cells.
- This method shows promise for generating islet cell sources for research or therapeutic applications.